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The 2.8 AÊ Crystal Structure of Visual Arrestin:
A Model for Arrestin's Regulation
the cytoplasmic surface of the receptor, thereby occlud-
ing interaction with the G proteins, a process referred to
as desensitization. Some arrestins also serve as adaptor
Joel A. Hirsch,²‖ Carsten Schubert,²‖
Vsevolod V. Gurevich,³ and Paul B. Sigler*²§
*Howard Hughes Medical Institute
²Department of Molecular Biophysics and Biochemistry molecules to the cellular protein trafficking machinery,
facilitating the receptor's sequestration by endocytosis.Yale University
New Haven, Connecticut 06511 This regulatory process is integrated with receptor func-
tion such that the kinase will only phosphorylate acti-³Ralph and Muriel Roberts Laboratory
for Vision Science vated receptors and the arrestins will only associate
with a receptor if it has been previously phosphorylated.Sun Health Research Institute
Sun City, Arizona 85372 The visual system is one of the best-studied GPCR
signaling pathways and has served as a paradigm for
its mode of action. In particular, the retinal rod cell and
its receptor, rhodopsin, provide a model for the pathwaySummary
due to its low noise, exquisite sensitivity, and enormous
dynamic range. Moreover, vision demands far greaterG protein±coupled signaling is utilized by a wide vari-
time resolution than other GPCR-mediated processes;ety of eukaryotes for communicating information from
therefore, rhodopsin kinase and visual arrestin mustthe extracellular environment. Signal termination is
quench the activated receptor very quickly. Thus, visualachieved by the action of the arrestins, which bind to
arrestin serves as a rapid, sensitive, and explicit ªoffactivated, phosphorylated G protein±coupled receptors.
switchº with selectivity for the cognate receptor that isWe describe here crystallographic studies of visual
both activated and phosphorylated. This strong selectiv-arrestin in its basal conformation. The salient features
ity is more pronounced in visual arrestin than other mem-of the structure are a bipartite molecule with an un-
bers of the family (Gurevich et al., 1995).usual polar core. This core is stabilized in part by an
We describe here the 2.8 AÊ crystal structure of recom-extended carboxy-terminal tail that locks the molecule
binant bovine visual rod arrestin, which together withinto an inactive state. In addition, arrestin is found to
biophysical, biochemical, and mutation studies, pro-be a dimer of two asymmetric molecules, suggesting
vides a structural framework for the molecular mecha-an intrinsic conformational plasticity. In conjunction
nism of arrestin and especially its proposed novel formwith biochemical and mutagenesis data, we propose
of regulation. For reasons made clear below and in aa molecular mechanism by which arrestin is activated
companion paper (Vishnivetskiy et al., 1999), we believefor receptor binding.
the conformation of free arrestin seen in this crystal
structure is designed to resist a stable interaction with
the receptor. It is the allosteric effect of the phosphory-Introduction
lated C-terminal segment of the receptor that alters ar-
restin's conformation, thereby promoting its binding toG protein±coupled receptor (GPCR) signaling is a path-
the activated receptor.way utilized by a wide variety of eukaryotic organisms
to communicate signals from the environment. These
signals range from photons to small molecule neuro- Results and Discussion
transmitters and odorants to polypeptide hormones.
The signals themselves activate membrane-embedded Structure Determination
Recombinant visual arrestin was expressed and purifiedreceptors, which have characteristic seven-transmem-
brane regions, by inducing a conformational shift whereby as described in Experimental Procedures. Two crystal
forms were obtained at 48C that diffracted to moderatethe activated receptor catalyzes the nucleotide ex-
change of heterotrimeric G proteins. The G protein sub- resolution. One form was solved and refined to 2.8 AÊ
resolution (C form); the other (P form) was solved byunits then propagate the signal to a variety of effector
molecules whose activities lead to physiological re- molecular replacement using the structure of the C form
as the search model and refined to 3.4 AÊ . As detailedsponses by the cell.
Cellular downregulation of this signaling pathway is below, each crystal form contains four molecules of
arrestin in the asymmetric unit. Two of these have onefine-tuned by a large cast of macromolecules (reviewed
in Krupnick and Benovic, 1998; Lefkowitz, 1998). The conformation (a) and two have a somewhat different
conformation (b). They are arranged such that one pairenzymatic activity of the receptor on its substrate, G
protein, is slowed by phosphorylation of the receptor (ab) is related by a local two-fold rotation axis to a
second pair (a9b9). The lattice is sparsely packed in boththrough the action of specific receptor kinases. Sub-
sequently, a family of intracellular inhibitory proteins crystal forms, leading to weak diffraction and making
synchrotron radiation mandatory. Electron density mapsdubbed arrestins terminate receptor activity. They bind
(Figure 1) were phased with multiple wavelength anoma-
lous diffraction from 23 selenomethionine-substituted§ To whom correspondence should be addressed (e-mail: sigler@
positions as well as both isomorphous and anomalouscsb.yale.edu).
‖ These authors contributed equally to this work. scattering differences from heavy atom replacements.
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372±404) is connected by a flexible linker (residues 362±
371) to the C domain. The C tail contains a short stretch
that forms a parallel b sheet interaction with the lateral
strand of the N domain. In addition, the C tail makes
other interactions with various parts of both the N and
C domains. The dimensions of the molecule are approxi-
mately 95 3 45 3 60 AÊ .
Arrestin appears to have a novel structure. A search
using the FSSP algorithm (Holm and Sander, 1998) for
similar structures yielded only previously solved b sand-
wich modules as observed in the N and C domains. No
structures in the PDB remotely resemble the topology
and domain orientation of full-length arrestin. The topol-
ogy diagram (Figure 3A), as well as the Ca trace of
the refined model, indicates strong structural similarity
between the N and C domains. This structural similarity
is only marginally reflected in a 19.3% sequence identity
(ALIGN) (Myers and Miller, 1988). In contrast, a rotation
of 1588 superimposes 97 of the 175 Ca atoms with a
root-mean-square deviation (rmsd) of 1.8 AÊ and a P
value of 10222 (Gerstein and Levitt, 1998). This P value
underscores the superimposition's statistical signifi-
cance.
The structural homology between domains is far
stronger than any homology with previously described
structures. The relatedness of the two individual do-
mains, their topological independence, and particularly
their arrangement relative to each other bear directly on
Figure 1. Electron Density their potential for conformational adjustments by en bloc
(A) Diagram of the solvent-flattened experimental electron density, domain rearrangements. Such shifts would be consis-
contoured at 1.5 s, showing parts of the polar core. The density for tent with arrestin's activation, as described below.
Phe-380 is clearly discernible in the experimental map, supporting Alignment of nine arrestin sequences based on this
our assignment of the C tail.
structure indicates that all members of this family will(B) Experimental phase combined 2Fo-Fc map, contoured at 1.8 s,
maintain a very similar fold (Figure 4). The most distantfrom the same region. Figures generated with O (Jones et al., 1991).
sequence, that of C. elegans, contains only two signifi-
cant inserts located in the loops between secondary
structural elements. The alignment suggests that criticalThe current model includes residues 8±362 and 372±
segments and residues implicated in function are highly394. Although density is present in experimental maps,
conserved. Clearly, there are two major families of ar-residues 363±371 have been modeled as polyalanine,
restin, one used in the visual systems (rod and cone)owing to their poorly defined nature, probable partial
and the other used in the balance of tissues. The twooccupancy, and high mobility. Similarly, residues 395±
families are distinguished by an insertion between the402 have been modeled as polyalanine for molecules a
C domain and the C tail (see below). This segment hasand a9 only, and their placement is provisional. No den-
been implicated in the interaction with clathrin endocyticsity is discernible for the amino-terminal six residues.
desensitization (Krupnick et al., 1997).A crystal structure of visual arrestin from bovine reti-
nae in the P crystal form was reported at 3.3 AÊ resolution
(Granzin et al., 1998). The structure described here dif- Oligomerization
Both crystal forms have an asymmetric unit comprisingfers significantly in biologically relevant ways from the
previous report. an arrestin tetramer. As noted above, there are two a
molecules and two b molecules, where a and b differ
only in their conformation. The protomers (an ab dimer)Molecular Architecture
Each molecule is composed of two domains where each are related by a single noncrystallographic two-fold axis.
Hence, the arrangement is a symmetrical dimer of abdomain is constructed from a seven-stranded b sand-
wich (Figures 2 and 3A). The sandwich comprises a four- heterodimers. The noncrystallographic two-fold sym-
metry facilitated the structure analysis. However, thestranded b sheet packed against a three-stranded b
sheet. Each domain contains an additional lateral strand. transformation relating the a and b molecules within the
protomeric dimer was not used; rather, both a and bThe two domains, named N domain (residue 8±180) and
C domain (residue 188±362), are related by an intramo- were built independently.
The quaternary structure observed in both crystallecular pseudo two-fold rotation axis. The N domain is
adorned with a single a helix, while the C domain con- forms and in the previously reported structure is the
same. This observation suggests that the oligomeriza-tains two short 310 helices in a long loop that provides
some of the interface between the two domains. The tion in the crystal is inherent to the chemistry of arrestin
rather than an artefact of the crystal packing and led usvery carboxyl terminus of the protein or ªC tailº (residues
A Structural Model for Arrestin's Regulation
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Figure 2. Structure of Arrestin
Stereo diagram of a ribbon drawing of the a conformer. The N and C domains are coded in pink and cyan, respectively; disordered regions
are shown in gray. Figure made with MOLSCRIPT/RASTER3D (Kraulis, 1991; Merritt and Bacon, 1997).
to investigate whether the same quaternary structure Role of Arrestin Plasticity
Molecules a and b of the heterodimer represent confor-was detectable in solution and is possibly biologically
relevant. A comprehensive analytical ultracentrifugation mationally different molecules. The rmsd of a and b
upon superposition is 3.0 AÊ for Ca atoms only. Thestudy was undertaken (C. S. et al., submitted). The solu-
tion experiments indicate that, at high concentration large difference is attributable to three discrete regions,
residues 68±79 (i), 155±165 (ii), and 337±347 (iii) (Figure(200 mM), arrestin is best modeled as a tetramer. How-
ever, at lower concentrations, arrestin participates in a 5); if one excludes those regions and some short sec-
ondary elements and linkers, the structure is the samemonomer/dimer equilibrium with a KD 5 34 (64) mM.
The most likely pairing of subunits in the dimer is shown (rmsd 5 0.7 AÊ for 338 Ca atoms). Region ii highlights
the remarkable plasticity of the protein. In a, region iiin a partial view in Figure 5C (C. S. et al., submitted).
The dimer interface between a and b involves two loci takes a helical conformation, whereas in b, it forms a
strand-turn-strand, forming an antiparallel b sheet inter-of interactions (Figures 5C and 5E). Importantly, dimer-
ization of a and b buries 2100 AÊ 2 of solvent-exposed action with a neighboring crystallographic symmetry
mate. The sequence falls into a hitherto rare but nowsurface area, a value that is well in the range for func-
tional dimers in solution (Jones and Thornton, 1995). emerging class of polypeptides, called ªchameleonsº
by Kim and coworkers, whose conformation is deter-Does the oligomerization observed in the crystal
structures and centrifugation data have any physiologi- mined by global environment rather than sequence (Mi-
nor and Kim, 1996). Recently, another natural chameleoncal relevance, and might it occur in vivo? Arrestin is the
second most abundant soluble protein in the rod outer structure was observed in the MCM protein dimer (Tan
and Richmond, 1998).segment (ROS). Estimates of its concentration range
from 50 to 167 mM (Hamm and Bownds, 1986; Kawa- A conformational heterodimer of proteins with identi-
cal sequences in the same crystal is not unprecedented.mura, 1995). Hence, a significant fraction of the arrestin
population in ROS will be dimeric. However, we know Antithrombin, a member of the serpin class of protease
inhibitors, exhibits a similar behavior wherein one of thethat arrestin is active as a monomer, since concentration
conditions where rhodopsin binding experiments are molecules of the dimer is found in the active state and
the other in the latent state (Carrell et al., 1994;performed are in the monomeric regime. Assuming that
the dimer is characteristic of the inactive state, its disso- Schreuder et al., 1994). In antithrombin, the two confor-
mations represent bona fide biologically relevant con-ciation might serve as an autoregulatory mechanism
whereby the steady-state concentration of monomeric formers. Likewise, arrestin's observed plasticity may
permit alternate local surfaces that the molecule willarrestin is held at the desired level. This mechanism
provides a large reserve of rapidly available arrestin present upon association with other macromolecular
partners such as a receptor. Indeed, regions i and iiwhen conditions require prompt and substantial desen-
sitization while preventing high concentrations of mono- (especially region i) contain both some degree of se-
quence conservation and solvent accessibility (Figuremeric arrestin from prematurely squelching a signal.
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network of hydrophobic and hydrogen bond interac-
tions, the striking feature of this core is the degree to
which these charged side chains are buried. Lys-176,
Arg-382, Arg-175, and Asp-296 have a total fractional
accessibility index of less than 10% (Lee and Richards,
1971), whereas Asp-30 and Asp-303 are partially solvent
accessible, with values of 25% and 35%, respectively.
Arrestin achieves sufficient charge neutrality to maintain
its structure by forming charge±charge interactions be-
tween Arg-382±Asp-30±Asp-303 and Arg-175±Asp-296.
Both computational and experimental work recently
have shown that the burial of ion pairs is, in general,
energetically unfavorable (Hendsch and Tidor, 1994;
Waldburger et al., 1995; Wimley et al., 1996; Sindelar et
al., 1998). A network of buried ion pairs such as that
observed here must impart an important function to the
molecule and/or specify a particular molecular architec-
ture in order to justify its energetic cost.
The polar core also provides a mechanism for facile
reorganization of the structure. Unlike the usual hy-
drophobic core of globular proteins whose structure
accommodates a wide range of changes in side chain
packing by small local adjustments in the fold (Lim and
Sauer, 1989; Matthews, 1995), changes in the delicate
balance of electrostatic charge in the polar core's sol-
vent-shielded environment are likely to lead to its sub-
stantial disruption.
The functional significance of this unique polar core
may lie in the role that receptor phosphorylation plays
in regulating the affinity of arrestin for the receptor.
Phosphorylation of the cytoplasmic C-terminal segment
of the activated receptor is the molecular switch thatFigure 3. Topology of Arrestin and Interactions of the C Tail
triggers arrestin's ability to avidly bind and inactivate(A) Folding pattern of arrestin showing the arrangement of second-
the receptor. It is clear that a specific arrestin-bindingary structure elements. The color coding is the same as in Figure
2; the C tail is displayed in yellow. Strands lying in the same sheet surface is not being created by phosphorylation of the
of a b sandwich are distinguished by light and dark hues. The internal C-terminal segment, since phosphorylation at any one
pseudo two-fold rotation axis is indicated by the black oval. or more of seven serine/threonine residues can activate
(B) Difference in secondary structure assignments between mole- the arrestin response (Aton et al., 1984; McDowell et al.,
cules a and b. Strands in common are indicated by roman numerals;
1993; Ohguro et al., 1994a, 1995). Rather, the biochemi-a helix by h; 310 helix by h*; helical conformation by h**; strand by
cal and mutagenesis data suggest that a phosphory-s. Secondary structure assignment is based on DSSP (Kabsch and
lated C-terminal segment represents a reagent closelySander, 1983).
(C) Schematic overview of the C tail (yellow) contacts separated into tethered to the receptor's surface that can activate ar-
electrostatic interactions (red arrows), hydrogen bond interactions restin, which normally exists in an inactive conformation
(black arrows), and van der Waals contacts (dotted lines). The hydro- (basal state). We believe that the intrusion of a phos-
gen bonds of the parallel b sheet interactions between strand I and phate moiety in or near the polar core would electrostati-
strand XX have been omitted for clarity.
cally destabilize this electroneutral network of polar in-
teractions and lead to significant rearrangement of
arrestin's conformation from the basal state visualized
4), suggestive of their functional importance for con- in the crystal structure to an active state that enables
served intermolecular interactions and not for folding or receptor binding.
architectural considerations within the molecule itself. The proposed disruption of the polar core can be
partially emulated by mutational changes. Mutations
The Polar Core of the Basal State that alter Arg-175, especially R175E (Gurevich and Be-
Figure 6A shows the most distinctive feature of arrestin's novic, 1997) (Figure 6B), abolish arrestin's ability to dis-
conformation, namely a polar core embedded between tinguish between Rho*-P (light-activated, phosphorylated
the N and C domains in the fulcrum of the molecule. rhodopsin) and Rho* (light-activated, nonphosphory-
This core structure comprises charged residues from lated rhodopsin), suggesting that this critical arginine
the very N terminus (Asp-30), the body of the N domain residue is at the center of the phosphorylation-sensitive
(Arg-175 and Lys-176), the interfacial loop of the C do- trigger. The structure shows that Arg-175 interacts with
main (Asp-296 and Asp-303), and the C tail (Arg-382). its negatively charged partners, constraining the mole-
These residues share a very high degree of sequence cule to its basal state. An electrostatic molecular surface
conservation, implying that the structure of this core representation (Figure 7B) shows that Arg-175 is located
region is conserved among all arrestins and is doubtless on the bottom of a deep positively charged groove. This
groove appears to be the most likely access route tocritical for function. Aside from exhibiting an elaborate
A Structural Model for Arrestin's Regulation
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Figure 4. Sequence Alignment and Structural Features of Arrestin
Sequence alignment between bovine visual arrestin (SWISSPROT accession number P08168), human rod arrestin (P10523), X. laevis cone
arrestin (P51483), D. melanogaster arrestins A and B (P15372, P19107), rat b-arrestin1 (P29066), bovine arrestin3 (P32120), trout arrestin
(P51466), and C. elegans arrestin (P51485). Green highlighting indicates highly conserved residues (8 of 9 identical), blue indicates conservative
substitutions, and conserved hydrophobic residues are highlighted in yellow. Surface accessibility is indicated by the height of the histograms
above the corresponding residue. Residues that could not be modeled with confidence are indicated as dots. Inserts (asterisks) were omitted
from the alignment for clarity, except for the insertion between residues 360 and 370, which contains the conserved clathrin-binding site in
the b-arrestin family. Phosphorylation sites are in red.
the polar core for the negatively charged C-terminal that Asp-296 and Arg-175 form an electrostatically and
structurally important ion pair that is the most criticalsegment of Rho*-P, since the opposite side of the mole-
cule as depicted in Figure 7B is blocked by the negative one in maintaining arrestin's basal state. Disruption of
this interaction leads to a constitutive enhancement ofsurface potential induced by Asp-296, Asp-30, and Asp-
303. We posit that upon arrestin's interaction with rho- arrestin's affinity for the receptor, drastically decreasing
its regulatory discrimination.dopsin's phosphorylated C-terminal segment, the polar
core interactions are disrupted and considerable re-
arrangement of arrestin occurs, indicated by the high C Tail: Structure and Function
The C tail was shown to be a crucial regulator for ar-Arrhenius activation energy of 140 kJ mol21 of binding
to Rho*-P (Schleicher et al., 1989; PulvermuÈ ller et al., restin's discrimination against Rho* (Palczewski et al.,
1991a). Its absence in the p44 splice variant (Palczewski1997).
Following a simplistic coulomb repulsion approach, et al., 1994) (residues 1±370) or its proteolytic removal
(Palczewski et al., 1991b) parallels to some degree theone would expect that reversing the charge of any of
the aspartate residues in the polar core would yield relaxation of specificity caused by charge reversal muta-
tions (e.g., R175E) in the polar core. Thus, unlike full-the same binding response as R175E, thus providing a
simple explanation for the mechanism of action. But the length arrestin, p44 binds to Rho*, as well as to Rho-P
(dark adapted, phosphorylated rhodopsin). Moreover,mutation that has the most significant effect is D296R
(Vishnivetskiy et al., 1999) (Figure 6B). Asp-296 is located the activation energy required to bind Rho*-P is reduced
in half, from 140 kJ mol21 to 70 kJ mol21 (PulvermuÈ llerin a ªlariatº loop (residues 283±304, blue chain in Figure
6A). The lariat is part of the interface between the N and et al., 1997). The structural basis for the C tail's role in
restraining arrestin in the inactive state is outlined inC domains. D296R is the only aspartate mutation that
binds nonphosphorylated Rho* in significantly enhanced Figures 3C and 6. The C tail participates in an extensive
network of mutagenically sensitive electrostatic, van derlevels in a manner similar to R175E. Moreover, R175E/
D296R (Vishnivetskiy et al., 1999) is the only single Waals, and hydrogen-bonded interactions including
those made by Arg-382 with Asp-30 and Asp-303, ascharge swap that restores wild-type activity. Together
with the structural information, these data demonstrate noted earlier in the description of the polar core.
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consistent with the effect of splicing, truncation, and
proteolytic modifications that, on the basis of the struc-
ture, would likely destabilize the polar core and mitigate
the stabilizing influence of the C tail. Such arrestin vari-
ants retain their affinity for Rho*-P but lose their ability
to discriminate against Rho* (Gurevich et al., 1994; Palc-
zewski et al., 1994).
The model calls for the release of activated arrestin's
C tail, which is compatible with the C tail's increased
accessibility to lysine modification (Ohguro et al., 1994b)
and accelerated proteolysis in the presence of Rho*-P
and not Rho*, a result that can also be induced by the
negatively charged heparin and the isolated phosphory-
lated C-terminal segment of rhodopsin alone (Palczew-
ski et al., 1991b; Puig et al., 1995). For example, experi-
ments with bovine calpain II (Azarian et al., 1995), a
protease that specifically cleaves between Phe-377 and
Glu-378, demonstrated that arrestin's C tail is sensitive
to proteolytic cleavage only in the presence of Rho*-P.
Another functional role of the C tail's displacement
upon arrestin binding to rhodopsin implies the un-
masking of binding sites for the receptor (Figure 8). Con-
sistent with this role, mutation of Leu-172 to Ala (Gure-
vich and Benovic, 1997) diminishes binding to Rho*-P
by 50%. With the C tail bound, as seen in the crystal
structure, Leu-172 is completely shielded (fractional ac-
cessibility ≈ 0%) but would become much more accessi-
ble (14%) upon release of the C tail.
Mutagenesis experiments show that in addition to the
stabilization provided by Arg-382 of the C tail (Vishnivet-
skiy et al., 1999), other residues help maintain the basalFigure 5. Plasticity of Arrestin and the ab Dimer Interface
state in a form that prevents binding to Rho*. The crystalThe central part of the figure shows a superposition of arrestin
conformers, with a (yellow) and b (cyan) drawn with the same orien- structure indicates that mutations which change Phe-
tation as Figure 2. The red highlighted segments are those that differ 375 and Phe-377 to Ala (Gurevich, 1998) would disrupt
in a and b due to the global environment. the interactions between these hydrophobic residues of
(A) The helical conformation of residues 155±165 (region ii in the text).
the C tail and helix I as well as strand I. These mutations(B) Region ii takes a strand-turn-strand conformation. Interface be-
result in a relaxation of specificity in the receptor bindingtween b and the crystallographic symmetry mate of b9 (green).
profile that resembles that of p44, in which the C tail is(C) Residues 68±79 (region i in the text) are depicted. In a, they are
in an extended strand conformation, making b sheet interactions, absent. Deletions of residues 11±16 of the N terminus,
whereas in b, they collapse into a loop. A portion of the dimer which interact with residues 375±377 (Figure 3C), also
interface between a and b is a parallel strand interaction, forming show a selectivity profile exhibiting markedly increased
a continuous sheet from one molecule to the next. This area extends Rho* binding (Vishnivetskiy et al., 1999).
over ten residues and involves side chain interactions as well.
Finally, the importance of the C tail in arrestin's regula-(D) Interface between a and b9 (cyan). Residues 337±347 (region iii
tory function is underlined by the fact that the majorityin the text) in a are in the strand conformation, involved in sheet
of the residues in the C tail, as well as the polar core,interactions with a molecular partner.
(E) Dimer interface between a and b; region iii in b is in an odd loop that stabilize the basal state and allow binding only to
conformation. This portion of the ab interface is noteworthy due to Rho*-P are highly conserved among all arrestins (Figure
its unusual interclasping of rolled sheet surfaces. Figure made with 4). This conservation suggests that the structural basis
GRASP (Nicholls et al., 1991). for the mechanism of activation proposed for visual ar-
restin is shared among all members of this molecular
Model for Arrestin's Activation family.
Based on the structural, biochemical, and mutational Our assignment of the C-terminal part of arrestin dif-
information, we present a model that explains how ar- fers with the previous reported structure of arrestin
restin's activity is regulated. We propose that the basal (Granzin et al., 1998), where the C terminus could only
state is maintained by the critical hydrogen-bonded salt be traced to residues 363 and 368 for molecules a/a9
bridges of the polar core and by interactions of the or b/b9, respectively. Rather, the first nine residues of
regulatory C tail. Upon binding, the receptor's negatively the N terminus were assigned positions where we place
charged phosphate ester disrupts the polar core and residues 375±384. There are multiple reasons why we
releases the C tail of arrestin. Together these events believe that our assignment is correct. First, experimen-
lead to a reorientation of the N and C domains that favors tal maps from this region (Figure 1) show unambiguous
the binding of arrestin to the activated, phosphorylated side chain density for the aromatic residues of the C
receptor. The disruption of the constraints would permit tail (Phe-375, Phe-377, Phe-380, and Tyr-391). Second,
a structural reorganization and thereby facilitate the for- mutations that disrupt the polar core should lead to
profound functional changes; however, mutations thatmation of an arrestin±receptor complex. This model is
A Structural Model for Arrestin's Regulation
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Figure 6. Close-Up View of the Polar Core
and the Functional Consequences of Its Per-
turbation
(A) Illustration of the hydrogen-bonded inter-
actions (green dotted lines) between residues
in the polar core including contributions from
the C tail and the lariat. The color coding is
the same as in Figure 2 except for the depic-
tion of the lariat loop from the C domain,
which is in blue. Figure made with MOL-
SCRIPT/RASTER3D.
(B) Histogram depicting the effect of muta-
tions in the polar core upon the binding to
Rho* as determined in three separate experi-
ments. All mutants bind Rho*-P and do not
bind Rho, essentially as wild type (WT). WT
and R175E are included as negative and posi-
tive controls for each series of experiments.
For additional data and experimental detail,
see Vishnivetskiy et al. (1999).
alter Lys-2 (Figure 6B), which in the previously reported position as Lys-2 does in the previously reported struc-
ture. Mutations of Arg-382, as noted earlier, show signifi-structure contributes to the polar core, have no effect
on the binding characteristics of arrestin (Vishnivetskiy cant binding to Rho* (Vishnivetskiy et al., 1999) (Figure
6B). We therefore believe that the positional assignmentet al., 1999). In our model, Arg-382 occupies the same
of Lys-2 and the associated N terminus in the structure
of Granzin et al. (1998) is in error. Third, proteolysis
studies (Palczewski et al., 1991a) indicate that the very
N terminus of arrestin is flexible, since trypsin is able to
cleave off the first two residues including Lys-2, a result
Figure 8. Footprint of the C Tail and Lysine Accessibilities
The footprint of the C tail on the molecular surface of arrestin is
illustrated in (A). Red colors indicate a 4 AÊ distance or less between
Figure 7. Electrostatic Potential Representation of Arrestin the C tail and the remainder of the molecule. The C tail's molecular
surface (red) has been detached and shifted away from the bodyElectrostatic potential of arrestin contoured at 1.5 kT (blue) and
21.5 kT (red) (ionic strength equivalent 0.1 M NaCl). The potential of the molecule. (B) shows the difference in the accessibility of
lysines toward acetylation upon binding of arrestin to Rho*-P com-map (A) is calculated with a model excluding marginally ordered
and disordered residues (i.e., 2±6, 364±373, and 395±404). The or- pared to background binding to Rho-P (based on Figure 6, 2 mM
panel, from Ohguro et al., 1994b). This either maps possible contactdered part of the C tail is drawn in green. The N domain is the left
half, and the C domain is the right half of the molecule. (B) shows points with the receptor or indicates locations of structural re-
arrangements upon binding of arrestin to activated rhodopsin. Redthe positive patch of charge potential on the N domain projected
onto a molecular surface representation. The location of the head indicates lysine residues that become more protected by Rho*-P;
orange, become more exposed by Rho*-P; purple, no detectablegroups of three essential polar core residues is outlined in the inset.
Note that these side chains are actually below the surface facing change. The molecular orientation is the same as Figure 2. Figures
made with GRASP and MOLSCRIPT/RASTER3D, respectively.away from the viewer. Figure generated with GRASP.
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that would be unlikely if Lys-2 would be fixed in the deuteroacetylated in the presence and absence of light-
activated, phosphorylated receptor. Residues on ar-polar core. Fourth, sequence conservation and muta-
tional sensitivity are the hallmarks of functionally impor- restin protected from chemical modification by the re-
ceptor mark regions that are most likely to be in contacttant segments of a given structure, and usually such
segments are well-ordered components of a crystal with rhodopsin. These residues are found on both do-
mains. Moreover, approximately 70 AÊ separates patchesstructure. As noted earlier, this is the case in our model,
where the conserved and mutationally sensitive resi- of protected lysine residues in each domain, while the
entire cytosolic surface of rhodopsin spans less thandues of the C tail make well-defined interactions, which
we posit are central to arrestin's regulatory mechanism. 40 AÊ (Schertler and Hargrave, 1995). This implies that
the activated form of arrestin must make a major confor-The C-terminal tail (369±404) is not visible in the pre-
viously reported structure. Finally, it is unlikely that the mational adjustment to protect lysine side chains in both
domains upon binding to receptor. It will be necessarydiscrepancies described above arise from differences
in crystal forms. We have independently solved and par- to pursue other approaches such as alanine scanning
mutagenesis in order to better define the residues re-tially refined the same crystal form (P) as that used in
the previous report and find that the apparent disorder quired for receptor binding and specificity. However,
taken together these results are consistent with our pro-of the N terminus and structure of the C tail are the
same in the P form as in the C form (presented in detail posal that after the phosphorylated receptor's C-termi-
nal segment interacts, a cooperative conformationalin this report).
switch occurs which alters the orientation between N
and C domains, thereby potentiating binding of bothReceptor Binding
domains to the receptor.Figure 7A illustrates the distribution of electrostatic po-
tential of arrestin. The N domain contains a significant
region of positive potential. The positively charged resi- Conclusions
dues in helix I (Arg-102, Lys-109, and Lys-110), which The biomedical importance of the desensitization ma-
give rise to the tear-shaped potential, are conserved, chinery in GPCR signaling is only now fully coming to
highly accessible, and undergo no ion pairing. Neither light. Malfunctioning of receptor phosphorylation has
lysine is protected from chemical modification upon ar- been implicated in cardiac pathology (Koch et al., 1995)
restin binding to rhodopsin, making it unlikely that they and hypertension (Gros et al., 1997). More specifically
participate in receptor binding (Ohguro et al., 1994b). in the visual system, the requirement for receptor phos-
This lack of interaction suggests that their role might be phorylation to obtain rapid quenching of the photore-
purely electrostatic, providing the necessary positive sponse was shown with mice containing a truncated
potential to orient arrestin with respect to the negatively rhodopsin gene that lacked the C-terminal segment con-
charged membrane surface. The N domain's proposed taining the sites of phosphorylation (Chen et al., 1995).
proximity to the membrane would facilitate interactions Furthermore, mutations in the human arrestin gene are
with the phosphorylated tail of rhodopsin by way of a believed to be responsible for a rare autosomal form
contiguous channel of positive potential that leads to of stationary night blindness called Oguchi's disease
the polar core (Figure 7A). (Fuchs et al., 1995). In parallel with this discovery,
Arrestin's receptor binding is the ultimate step in the transgenic arrestin knockout mice were shown to have
quenching of rhodopsin activity. We propose that a re- prolonged photoresponses, consistent with the human
orientation of the N and C domains presents both of genetic data (Xu et al., 1997).
their respective surfaces for association with rhodopsin. Based on the structural data presented here in combi-
The involvement of both domains in the binding is sup- nation with other experiments, we have proposed a hy-
ported by the available evidence as outlined below and pothesis for arrestin's molecular mechanism. Arrestin's
is in contrast to the model presented by Granzin and basal state is analogous in some respects to that of a
coworkers (1998). zymogenic proprotease that subsequently undergoes ac-
Truncation and deletion studies implicated the N do- tivation. Unlike the zymogen, no covalent bonds are
main as a primary domain of interaction, but that data broken, but rather the receptor's phosphorylated C-ter-
also showed that the C domain was also likely to play minal segment induces a conformational change in ar-
a significant role in the binding (Gurevich and Benovic, restin to create a binding-competent form that binds
1993). More recent experiments, which involved con- selectively to the cytosolic surface of the activated re-
struction of chimeric molecules of visual arrestin and ceptor. The exact nature of arrestin's activated confor-
b-arrestin (Gurevich et al., 1995), furnish a more convinc- mation and the stereochemistry of receptor recognition
ing demonstration that both the N and C domains play awaits the elucidation of the structure of a receptor±
a role in binding the activated, phosphorylated receptor. arrestin complex.
Arrestin was divided approximately into the N terminus,
N domain, C domain, and C tail. Both the N and C domains Experimental Procedures
played a dominant role in providing specificity for the
Expression and Purification of Arrestincognate receptor, while the N terminus and C tails did
Recombinant arrestin was expressed and purified as describednot play significant roles in specifying receptor type.
(C. S. et al., submitted). Selenomethionine-substituted arrestin wasClose analysis of chemical protection experiments of
expressed in the methionine auxotroph E. coli strain B834 (Novagen)
arrestin (Ohguro et al., 1994b) in light of the structure is in a MOPS-based minimal media (Neidhardt et al., 1974), supple-
again consistent with a model where receptor interacts mented with 50 mg l21 L-selenomethionine (Sigma). Purification was
carried out as for unsubstituted arrestin except that all buffers werewith both domains (Figure 8B). Lysine residues were
A Structural Model for Arrestin's Regulation
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sparged with argon to prevent oxidation and the protein was imme- A complete and self-consistent set of sites was developed for the
selenium, iridium, and ethyl mercury derivatives by cross-differencediately used for crystallization. Selenomethionine substitution was
Fourier analysis at low resolution. At that stage, derivative (additionalconfirmed by mass spectrometry.
derivatives as listed in Table 1 were identified by cross-difference
Fourier analysis) and native data sets with an Rmerge , 20% wereCrystallization
combined into one of two classes and the phase determination
Crystals were grown using the hanging drop method and microseed-
branched. One phase set (class A) was obtained from the seleno-
ing at 48C. The reservoir solution consisted of 100 mM Tris-HCl (pH methionine derivative (MAD), a native, and two other heavy atom
8.5±8.8), 200 mM ammonium or sodium acetate, and 22%±25% derivatives. The other phase set (class B) was derived from the
isopropanol. Microseeding stock was prepared by crushing two or isomorphous differences between the parent and heavy atom deriv-
three large crystals in a stabilizing supernatant of 100 mM Tris-HCl atives augmented by the associated single wavelength Bijvoet dif-
(pH 8.5±8.8), 200 mM ammonium acetate or sodium acetate, and ferences of the derivatives (MIRAS). PHASES was used to prepare
30% isopropanol and diluting the suspension serially. Protein stock an initial solvent-flattened map based on isomorphous and Bijvoet
(1±4 ml at 10 mg ml21) was mixed with reservoir and microseed differences from class A data. This map clearly showed the noncrys-
solution in a ratio of 2:1:1, respectively. Crystals grew within 1 week tallographic two-fold and polypeptide chain. Final heavy atom and
to an average final size of approximately 50 3 250 3 250 mm. Heavy MAD refinement of both classes utilized SHARP (de La Fortelle and
atom soaks were prepared by adding concentrated heavy atom Bricogne, 1997). Refinement of class A data was aided by phase
solutions (listed in Table 1) directly to drops (initial volume 5 2±3 information from the nonisomorphous class B phase set, and phases
ml) containing crystals after addition of 2 ml of reservoir solution. from both classes were improved by density modification (SOLO-
Crystals were frozen by transfer (several seconds) into cryoprotec- MON) (Abrahams and Leslie, 1996). Two-fold averaging in RAVE
(Kleywegt and Jones, 1994) improved side chain definition in sometant solution (100 mM Tris-HCl [pH 8.5], 200 mM ammonium or
areas of the maps but did not significantly improve main chainsodium acetate, 40% isopropanol, 14% xylitol) and then immersion
density. The use of selenium positions during model building in Oin liquid propane. For the preparation of native and selenomethionyl
(Jones et al., 1991) and the excellent quality of the electron densityprotein crystals, the cryoprotectant also contained 1±10 mM magne-
maps enabled approximately 90%±95% of the model, including sidesium acetate, which reduced anisotropic mosaic spread to tolerable
chains, to be built from both the class A and B experimental mapsvalues (z18). ªPseudo nativeº crystals with improved diffraction
independently in the first round. Refinement of both models in CNS,quality were obtained by adjusting the drop concentration to 10 mM
guided by the Rfree (BruÈ nger, 1992) consisted of multiple cycles oflead(II) acetate. In the majority of cases, arrestin crystallized in space
torsion angle simulated annealing and B factor refinement includinggroup C2221 (C form) with typical cell dimensions of a 5 168 AÊ , b 5
bulk solvent correction and manual rebuilding. The models were193 AÊ , c 5 191 AÊ . The same conditions also yielded a primitive
restrained tightly to their noncrystallographic two-fold symmetryorthorhombic form in space group P21212 with cell dimensions a 5
except for regions that were clearly different due to differing packing168.4 AÊ , b 5 187.8 AÊ , c 5 90.5 AÊ (P form).
environments as judged by sA weighted 2Fo-Fc difference maps.
Stereochemical tests by PROCHECK (Laskowski et al., 1993) indi-
Data Collection and Structure Determination cate that the structure is within the idealized targets for its resolution.
The MAD experiment used recombinant selenomethionyl arrestin, The two structures produced in the branched phasing scheme are
while MIRAS experiments used heavy atom derivatized crystals. essentially identical with an rmsd of 0.6 AÊ for corresponding Ca
Due to the weak inherent order of both crystal forms, usable data atoms.
were obtained only at insertion device synchrotron sources. There- The structure of the primitive (P) crystal form was solved by molec-
fore, the MAD experiment required an undulator beamline in order to ular replacement with CNS using a partially refined model of the C
form (tetrameric model) as a search structure. A fast direct rotationprovide sufficient intensity for accurate measurement of the Bijvoet
search showed a top peak (correlation coefficient 5 16.6%) 4.3pairs.
times greater than the next peak. A translation search gave a solutionNative and derivative data were collected at 100 K with synchro-
with a 61% correlation coefficient. Refinement of the four moleculestron radiation as detailed in Table 1. The oscillation range was usu-
as rigid bodies resulted in an R factor of 36%. Subsequently, theally 0.38 to 0.58 except for data from the F1 beamline (CHESS) where
model was refined as above. Composite simulated annealing omit18 oscillations were used. For heavy atom derivatives, the wave-
maps were used to confirm that the molecular models were essen-length was tuned where possible to the absorption edge and the
tially the same in the C and P forms. In particular, there was noinverse beam technique was used to collect the Friedel pairs. A
density observed for the first amino-terminal eight residues, and thefour-wavelength selenomethionine (MAD) experiment (Hendrickson,
C tail is represented by contiguous density with appreciable side1991) was performed on the ID19 beamline at Advanced Photon
chain density in sA weighted 2Fo-Fc difference maps.Source. Data were collected at the anticipated peak of the absorp-
tion edge (l1), its presumed inflection point (l2), and low (l3) and
Acknowledgmentshigh (l4) energy remote points. (Subsequent data analysis indicated
that, due to flawed fluorescence spectra, both l1 and l2 data sets
This paper is dedicated to the memory of our colleague and friend,straddled the Se absorption peak.) All data sets were processed
Serge Pares, who helped initiate this project. He and his wife arewith DENZO and SCALEPACK (Otwinowski and Minor, 1997).
deeply missed. We are indebted to members of the Sigler lab for
Crystals of the C form showed a high degree of nonisomorphism
their help in data collection (R. Albright, R. Gaudet, T. Kawashima,
between data sets, manifesting itself in a high Rmerge of up to 40% Y. Korkhin, G. Meinke, and F. Tsai). We thank the staffs of NSLS
(based on intensities) and a 2% variation of cell dimensions, espe- (Dr. L. Berman and Dr. M. Capel), MacCHESS, and APS-SBC
cially the b axis. This nonisomorphism made it necessary to divide (Dr. A. Joachimiak), Dr. W. Minor and Dr. Z. Otwinowski for a prere-
the data sets into two more isomorphous subclasses and to pursue lease of HKL2000, Dr. G. Olack for mass spectrometry, Dr. E. de la
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Note Added in Proof
The data referred to throughout as ``C.S. et al., submitted'' are now
in press: Schubert, C., Hirsch, J.A., Gurevich, V.V., Engelman, D.M.,
and Sigler, P.B. (1999). Visual arrestin activity may be regulated by
self-association. J. Biol. Chem.
